Krystal Biotech
KRYS
KRYS
108 hedge funds and large institutions have $836M invested in Krystal Biotech in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.88% less ownership
Funds ownership: 73.48% → 70.6% (-2.9%)
Holders
108
Holding in Top 10
1
Calls
$2.53M
Puts
–
Top Buyers
| 1 | +$12.6M | |
| 2 | +$10.8M | |
| 3 | +$10.4M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$9.21M |
| 5 |
DP
DSAM Partners
London,
United Kingdom
|
+$5.26M |
Top Sellers
| 1 | -$22.6M | |
| 2 | -$20.8M | |
| 3 | -$9.83M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$5.01M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.61M |